Hear an expert panel review currently available data on cancer care disparities, discuss the needs of disadvantaged populations, and share practical solutions and methods for implementing bias training and bidirectionally engaging your cancer program or practice with local community representatives

The COVID-19 pandemic has thrown a wrench into every corner of the American healthcare system, and clinical research is no exception. In light of physical distancing and public safety recommendations, research programs have made significant adjustments, including virtual approaches to site selection and data collection and increased use of telehealth services. What lessons about clinical research can be learned during the pandemic, and what does it mean for the future of cancer research?

The David King Community Clinical Scientist Award recognizes individuals who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.

The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community.

The Annual Achievement Award recognizes individuals or an organization who have made outstanding contributions, nationally and/or internationally, to cancer care and to patients with cancer.

Optimal care delivery changes from place to place—what works best for one location and patient population may not be ideal for another. The same applies to cancer research. Understanding the needs of your patient population is critical to trial design and implementation. How can you proactively involve your community in cancer research activities? ​

Community cancer centers are fast becoming sites for biomarker testing and precision medicine. As clinical research becomes a larger part of community cancer center operations, strengthening tissue collection procedures and considering the establishment of biospecimen repositories are critical concerns.

Tune in to a panel discussion around key results from a recent nationwide survey on the role of oncology advanced practitioners in cancer clinical research including current barriers to optimal care coordination and opportunities to maximize the involvement and impact of APs on the cancer research team.

Hear strategies to improve clinical trial accrual for racial and ethnic minorities, as well as other at-risk groups. Dr. Nadine Barrett will also explore successful solutions for working with community organizations to enhance interest and enrollment in clinical research.

Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.